Your browser doesn't support javascript.
loading
Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Lembo, Anthony; Pimentel, Mark; Rao, Satish S; Schoenfeld, Philip; Cash, Brooks; Weinstock, Leonard B; Paterson, Craig; Bortey, Enoch; Forbes, William P.
Afiliación
  • Lembo A; Beth Israel Deaconess Medical Center, Boston, Massachusetts. Electronic address: alembo@bidmc.harvard.edu.
  • Pimentel M; Cedars-Sinai Medical Center, Los Angeles, California.
  • Rao SS; Regents University, Augusta, Georgia.
  • Schoenfeld P; University of Michigan, Ann Arbor, Michigan.
  • Cash B; University of South Alabama, Mobile, Alabama.
  • Weinstock LB; Washington University School of Medicine, Specialists in Gastroenterology, St. Louis, Missouri.
  • Paterson C; Salix Pharmaceuticals, Raleigh, North Carolina.
  • Bortey E; Salix Pharmaceuticals, Raleigh, North Carolina.
  • Forbes WP; Salix Pharmaceuticals, Raleigh, North Carolina.
Gastroenterology ; 151(6): 1113-1121, 2016 12.
Article en En | MEDLINE | ID: mdl-27528177

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rifamicinas / Síndrome del Colon Irritable / Antiinfecciosos Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rifamicinas / Síndrome del Colon Irritable / Antiinfecciosos Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Gastroenterology Año: 2016 Tipo del documento: Article